PMID- 35508623 OWN - NLM STAT- MEDLINE DCOM- 20220506 LR - 20220716 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 12 IP - 1 DP - 2022 May 4 TI - Pulsed electromagnetic fields inhibit mandibular bone deterioration depending on the Wnt3a/beta-catenin signaling activation in type 2 diabetic db/db mice. PG - 7217 LID - 10.1038/s41598-022-10065-7 [doi] LID - 7217 AB - Type 2 diabetes mellitus (T2DM) patients have compromised mandibular bone architecture/quality, which markedly increase the risks of tooth loosening, tooth loss, and failure of dental implantation. However, it remains lacks effective and safe countermeasures against T2DM-related mandibular bone deterioration. Herein, we studied the effects of pulsed electromagnetic fields (PEMF) on mandibular bone microstructure/quality and relevant regulatory mechanisms in T2DM db/db mice. PEMF exposure (20 Gs, 15 Hz) for 12 weeks preserved trabecular bone architecture, increased cortical bone thickness, improved material properties and stimulated bone anabolism in mandibles of db/db mice. PEMF also upregulated the expression of canonical Wnt3a ligand (but not Wnt1 or Wnt5a) and its downstream beta-catenin. PEMF improved the viability and differentiation of primary osteoblasts isolated from the db/db mouse mandible, and stimulated the specific activation of Wnt3a/beta-catenin signaling. These positive effects of PEMF on mandibular osteoblasts of db/db mice were almost totally abolished after Wnt3a silencing in vitro, which were equivalent to the effects following blockade of canonical Wnt signaling using the broad-spectrum antagonist DKK1. Injection with Wnt3a siRNA abrogated the therapeutic effects of PEMF on mandibular bone quantity/quality and bone anabolism in db/db mice. Our study indicates that PEMF might become a non-invasive and safe treatment alternative resisting mandibular bone deterioration in T2DM patients, which is helpful for protecting teeth from loosening/loss and securing the dental implant stability. CI - (c) 2022. The Author(s). FAU - Li, Jianjun AU - Li J AD - Second Clinical Division, Peking University School and Hospital of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, 22 Zhongguancun South Avenue, Beijing, 100081, China. dentistlijianjun@163.com. AD - Beijing Healya Technology Limited, Beijing, 100195, China. dentistlijianjun@163.com. FAU - Cai, Jing AU - Cai J AD - College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, China. FAU - Liu, Liheng AU - Liu L AD - Department of Obstetrics, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China. FAU - Wu, Yuwei AU - Wu Y AD - Second Clinical Division, Peking University School and Hospital of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, 22 Zhongguancun South Avenue, Beijing, 100081, China. FAU - Chen, Yan AU - Chen Y AD - Second Clinical Division, Peking University School and Hospital of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, 22 Zhongguancun South Avenue, Beijing, 100081, China. LA - eng PT - Journal Article DEP - 20220504 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (WNT3A protein, human) RN - 0 (Wnt3A Protein) RN - 0 (beta Catenin) SB - IM MH - Animals MH - *Diabetes Mellitus, Type 2/complications/metabolism/therapy MH - Electromagnetic Fields MH - Humans MH - Mandible/metabolism MH - Mice MH - Wnt Signaling Pathway/physiology MH - Wnt3A Protein MH - *beta Catenin/metabolism PMC - PMC9068619 COIS- The authors declare no competing interests. EDAT- 2022/05/05 06:00 MHDA- 2022/05/07 06:00 PMCR- 2022/05/04 CRDT- 2022/05/04 23:47 PHST- 2021/08/04 00:00 [received] PHST- 2022/03/01 00:00 [accepted] PHST- 2022/05/04 23:47 [entrez] PHST- 2022/05/05 06:00 [pubmed] PHST- 2022/05/07 06:00 [medline] PHST- 2022/05/04 00:00 [pmc-release] AID - 10.1038/s41598-022-10065-7 [pii] AID - 10065 [pii] AID - 10.1038/s41598-022-10065-7 [doi] PST - epublish SO - Sci Rep. 2022 May 4;12(1):7217. doi: 10.1038/s41598-022-10065-7.